ROCK and Rolling Towards Predicting BCR-ABL Kinase Inhibitor-Induced Vascular Toxicity

JACC CardioOncol. 2022 Sep 20;4(3):384-386. doi: 10.1016/j.jaccao.2022.07.001. eCollection 2022 Sep.

Authors

Jenica N Upshaw¹, Richard Travers^{2

3}, Iris Z Jaffe^{1

3}

Affiliations

¹ Division of Cardiology, Tufts Medical Center, Boston, Massachusetts, USA.
² Division of Hematology Oncology, Tufts Medical Center, Boston, Massachusetts, USA.
³ Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts, USA.

No abstract available

Keywords: BCR-ABL kinase inhibitors; chronic myeloid leukemia; endothelial cell; vascular toxicity.

Publication types

Editorial

Grants and funding